(R)-tert-Butyl 2-((methylamino)methyl)piperidine-1-carboxylate

Catalog No. :
ACHOGC053
CAS No. :
783325-29-1
Molecular Formula :
C12H24N2O2
Molecular Weight :
228.34

IUPAC Name:tert-butyl (R)-2-((methylamino)methyl)piperidine-1-carboxylate

(R)-tert-Butyl 2-((methylamino)methyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$883.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 2-((methylamino)methyl)piperidine-1-carboxylate
IUPAC Nametert-butyl (R)-2-((methylamino)methyl)piperidine-1-carboxylate
MDL No.MFCD12828806
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESO=C(N1[C@@H](CNC)CCCC1)OC(C)(C)C
InChI KeyMDSFYYLVYHYPGW-SNVBAGLBSA-N
Synonym1-N-BOC-2-N'-METHYL-AMINO PIPERIDINE;tert-Butyl 2-(MethylaMino)piperidine-1-carboxylate;1-N-BOC-2-(N'-METHYL-AMINOMETHYL)PIPERIDINE;(R)-tert-butyl 2-((methylamino)methyl)piperidine-1-carboxylate;(2R)-2-[(Methylamino)methyl]-1-piperidinecarboxylic acid tert-butyl ester;N-Boc-2-N-Methyl-aMinoMethyl piperidine;tert-butyl (R)-2-((methylamino)methyl)piperidine-1-carboxylate;(2R)-tert-butyl 2-((methylamino)methyl)piperidine-1-carboxylate
CAS No.783325-29-1

Synthetic Route by SureRoute

1. ACHOGC053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIKXE193 route compound structure diagram
    ACIKXE193134526-69-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHOGC053 route product structure diagram
    ACHOGC053783325-29-1
Inquiry

2. ACHOGC053 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTPIU167 route compound structure diagram
    ACTPIU167150521-32-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHOGC053 route product structure diagram
    ACHOGC053783325-29-1
Inquiry

Comments (0)